)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Rohto Pharmaceutical (4527) investor relations material
Rohto Pharmaceutical Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary13 Nov, 2025
Executive summary
Sales increased 18.1% year-over-year to 164,257 million yen, with double-digit growth in Asia and Europe, and all regions showing sales increases, driven by strong domestic and overseas demand and recent acquisitions.
Operating income rose 8.6% year-over-year to 19,317 million yen, ahead of plan, with ordinary income up 32.4% and profit attributable to owners of parent up 36.6%.
Full-year forecasts for sales, operating income, ordinary income, and net profit were revised upward, with record highs expected.
Annual dividend increased to 43 yen per share, marking 22 consecutive years of dividend growth.
The company finalized provisional accounting for business combinations, impacting comparative figures.
Financial highlights
1H FY2026 sales: 164,257 million yen (+18.1% YoY); operating income: 19,317 million yen (+8.6% YoY); EBITDA: +23.2% YoY.
Gross profit reached 91,183 million yen, up from 78,507 million yen year-over-year; gross profit margin: 55.5%.
Profit attributable to owners of parent: 17,652 million yen (+36.6% YoY); net income per share: 78.12 yen.
Exchange rates negatively impacted sales by 2,090 million yen and operating income by 140 million yen.
Cash and cash equivalents at period-end were 74,066 million yen, up 845 million yen from the previous fiscal year-end.
Outlook and guidance
Full-year FY2026 sales forecast revised up to 338,500 million yen (+9.7% YoY); operating income to 39,500 million yen (+3.3% YoY); ordinary income: 44,000 million yen (+10.8% YoY); net profit: 32,000 million yen (+3.8% YoY).
Dividend forecast raised to 43 yen per share for the fiscal year ending March 31, 2026; dividend payout ratio estimated at 30.4%.
Upward revisions driven by strong 1H performance in Japan, Asia, and Americas; continued growth expected in Southeast Asia.
Exchange rate assumptions revised to 148 yen/USD and 20 yen/CNY for the forecast period.
Europe segment profit recovery plan
Obagi Japan trademark acquisition rationale
Foreign currency impact on comprehensive income?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Rohto Pharmaceutical earnings date
Q3 202612 Feb, 2026
Next Rohto Pharmaceutical earnings date
Q3 202612 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Rohto Pharmaceutical Co., Ltd. is a Japanese multinational corporation specializing in health and beauty care products. The company's main business activities include the manufacture and sale of pharmaceutical products, cosmetics, and functional foods. Rohto Pharmaceutical's product range spans eye care, including eye drops and lotions; skincare, featuring dermatological preparations, lip balms, and sunscreens; and oral medications, which include digestive medicines and Chinese herbal supplements. Additionally, the company offers extracorporeal test drugs and various other health-related products. The company is headquartered in Osaka, Japan, and its shares are listed on the Tokyo Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage